General Information of Drug Transporter (DT)
DT ID	DTD0002 Transporter Info
Gene Name	ABCC2
Protein Name	Multidrug resistance-associated protein 2
Gene ID	1244
UniProt ID	Q92887
Genetic Polymorphisms of DT (GPD)
Genetic Polymorphism	rs113646094
Site of GPD	chr10:99804255 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	C>G / C>T
Minor Allele Frequency	G=0.0032/16 (Global)
Genotype CG	Click to Show/Hide the Full List of Affected Drugs:            2 Drugs in Total
Pravastatin	Drug Info	Healthy Individuals	Correlated with the increased drug clearance in healthy individuals (compare with genotype CC)		[ 1]
Pravastatin	Drug Info	Hypercholesterolemia	Correlated with the increased expression of ABCC2 mRnA in human liver samples (compare with genotype CC)		[ 1]
Genetic Polymorphism	rs12762549
Site of GPD	chr10:99861014 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	C>G / C>T
Minor Allele Frequency	G=0.4806/2407 (Global)
Genotype CC	Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Docetaxel	Drug Info	Neoplasm	Irrelevant to the neutropenia in patients (compare with genotypes CG + GG)		[ 2]
Genotypes CG + GG	Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Docetaxel	Drug Info	Breast Neoplasm	Correlated with the decreased drug clearance (compare with genotype CC)		[ 2]
Genetic Polymorphism	rs17222723
Site of GPD	chr10:99836239 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	T>A
Minor Allele Frequency	A=0.0373/187 (Global)
Allele A	Click to Show/Hide the Full List of Affected Drugs:            2 Drugs in Total
Tenofovir	Drug Info	HIV Infection	Correlated with the decreased renal proximal tubulopathy risk in patients (compare with Allele T); Irrelevant to the increased kidney tubular dysfunction risk in patients (compare with Allele T)		[ 3], [ 4]
Doxorubicin	Drug Info	Non-Hodgkin Lymphoma	Correlated with the increased cardiotoxicity risk in patients (compare with Allele T)		[ 5]
Genetic Polymorphism	rs2273697
Site of GPD	chr10:99804058 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	G>A
Minor Allele Frequency	A=0.1865/934 (Global)
Allele A	Click to Show/Hide the Full List of Affected Drugs:            6 Drugs in Total
Mycophenolic acid	Drug Info	Kidney Transplantation	Correlated with the decreased drug exposure in patients (compare with allele G)		[ 6]
Tenofovir	Drug Info	HIV Infection	Correlated with the increased renal proximal tubulopathy risk in patients (compare with allele G); Irrelevant to the increased fanconi syndrome risk in patients (compare with Allele G); Irrelevant to the increased kidney tubular dysfunction risk in patients (compare with Allele G); Irrelevant to the likelihood of kidney diseases in patients (compare with Allele G)		[ 3], [ 4], [ 7], [ 8]
Methotrexate	Drug Info	Rheumatoid Arthritis	Irrelevant to the drug discontinuation in patients (compare with allele G)		[ 11]
Carbamazepine	Drug Info	Epilepsy	Irrelevant to the number of seizures per year in patients (compare with Allele G)		[ 12]
Oxcarbazepine	Drug Info	Epilepsy	Irrelevant to the number of seizures per year in patients (compare with Allele G)		[ 12]
Antiepileptics	N.A.	Epilepsy	Correlated with the increased probability of drug response in patients (compare with allele G); Irrelevant to the drug resistance in patients (compare with Allele G); Irrelevant to the drug resistance in patients (compare with Allele G); Irrelevant to the number of seizures per year in patients (compare with Allele G)		[ 12], [ 13], [ 14], [ 15]
Allele G	Click to Show/Hide the Full List of Affected Drugs:            4 Drugs in Total
Mycophenolic acid	Drug Info	Kidney Transplantation	Irrelevant to the drug metabolism in patients (compare with allele A)		[ 14]
Carbamazepine	Drug Info	Epilepsy	Irrelevant to the increased drug resistance in patients (compare with allele A)		[ 15]
Oxcarbazepine	Drug Info	Epilepsy	Irrelevant to the increased drug resistance in patients (compare with allele A)		[ 15]
Antiepileptics	N.A.	Epilepsy	Irrelevant to the increased drug resistance in patients (compare with allele A)		[ 15]
Genotype AA	Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Methotrexate	Drug Info	Rheumatoid Arthritis	Correlated with the increased likelihood of drug toxicity in patients (compare with genotypes AG + GG)		[ 16]
Genotype AG	Click to Show/Hide the Full List of Affected Drugs:            4 Drugs in Total
Mycophenolic acid	Drug Info	Lung Transplantation	Correlated with the increased drug concentrations in patients (compare with genotype GG)		[ 17]
Carbamazepine	Drug Info	Epilepsy	Correlated with the relationship with drug resistance in patients (compare with genotype GG)		[ 18]
Oxcarbazepine	Drug Info	Epilepsy	Correlated with the relationship with drug resistance in patients (compare with genotype GG)		[ 18]
Exjade	N.A.	Beta-Thalassemia	Correlated with the increased drug concentrations in patients (compare with genotype GG)		[ 19]
Genotype GG	Click to Show/Hide the Full List of Affected Drugs:            4 Drugs in Total
Fluorouracil	Drug Info	Breast Neoplasm	Correlated with the increased anemia risk in patients (compare with genotypes AA + AG)		[ 20]
Doxorubicin	Drug Info	Breast Neoplasm	Correlated with the increased anemia risk in patients (compare with genotypes AA + AG)		[ 20]
Cyclophosphamide	Drug Info	Breast Neoplasm	Correlated with the increased anemia risk in patients (compare with genotypes AA + AG)		[ 20]
Mycophenolic acid	Drug Info	Kidney Transplantation	Irrelevant to the any pharmacokinetic parameters measured in the study in patients (compare with genotype AA)		[ 21]
Genotypes AA + AG	Click to Show/Hide the Full List of Affected Drugs:            6 Drugs in Total
Irinotecan	Drug Info	Colorectal Neoplasm	Correlated with the increased drug metabolism in patients (compare with genotype GG)		[ 22]
Carbamazepine	Drug Info	Epilepsy	Correlated with the increased neurological ADR risk in patients (compare with genotype GG); Irrelevant to the drug response in patients (compare with genotype GG)		[ 23], [ 24]
Cisplatin	Drug Info	Mesothelioma	Correlated with the increased overall survival and progression-free survival in patients (compare with genotype GG)		[ 25]
Pemetrexed	Drug Info	Mesothelioma	Correlated with the increased overall survival and progression-free survival in patients (compare with genotype GG)		[ 25]
Tenofovir	Drug Info	HIV Infection	Irrelevant to the glomerular disease in patients (compare with genotype GG)		[ 26]
Antiepileptics	N.A.	Epilepsy	Irrelevant to the increased drug resistance in patients (compare with genotype GG)		[ 10]
Genetic Polymorphism	rs3740065
Site of GPD	chr10:99845936 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	A>G
Minor Allele Frequency	G=0.2011/1007 (Global)
Genotype AA	Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Tamoxifen	Drug Info	Breast Neoplasm	Correlated with the increased recurrence of breast cancer risk in patients (compare with genotype GG)		[ 27]
Genotype AG	Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Tamoxifen	Drug Info	Breast Neoplasm	Irrelevant to the disease recurrence risk in patients (compare with genotype AA)		[ 28]
Genotypes AG + GG	Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Methotrexate	Drug Info	Acute B-Cell Leukemia	Correlated with the increased drug plasma level in patients (compare with genotype AA); Correlated with the increased toxicity risk in patients (compare with genotype AA)		[ 29]
Genetic Polymorphism	rs3740066
Site of GPD	chr10:99844450 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	C>G / C>T
Minor Allele Frequency	T=0.2881/1443 (Global)
Allele C	Click to Show/Hide the Full List of Affected Drugs:            2 Drugs in Total
Mycophenolic acid	Drug Info	Kidney Transplantation	Irrelevant to the drug metabolism in patients (compare with Allele T)		[ 14]
Antiepileptics	N.A.	Epilepsy	Irrelevant to the drug resistance in patients (compare with Allele T)		[ 11]
Allele T	Click to Show/Hide the Full List of Affected Drugs:            2 Drugs in Total
Tacrolimus	Drug Info	Kidney Transplantation	Irrelevant to the drug trough concentration in patients (compare with allele C)		[ 30]
Antiepileptics	N.A.	Epilepsy	Irrelevant to the number of seizures per year in patients (compare with allele C)		[ 10]
Genotype CC	Click to Show/Hide the Full List of Affected Drugs:            2 Drugs in Total
Irinotecan	Drug Info	Non-Small-Cell Lung Carcinoma	Correlated with the increased diarrhea risk in patients (compare with Genotypes CT + TT); Irrelevant to the neutropenia in patients (compare with Genotypes CT + TT)		[ 31]
Mycophenolic acid	Drug Info	Organ Transplantation	Irrelevant to the any pharmacokinetic parameters measured in the study (compare with Genotype TT)		[ 21]
Genotype CT	Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Mycophenolic acid	Drug Info	Lung Transplantation	Correlated with the decreased drug concentrations in patients (compare with genotypes CC + tt)		[ 17]
Genotype TT	Click to Show/Hide the Full List of Affected Drugs:            5 Drugs in Total
Fluorouracil	Drug Info	Breast Neoplasm	Correlated with the increased neutropenia risk in patients (compare with genotypes CC + CT)		[ 20]
Doxorubicin	Drug Info	Breast Neoplasm	Correlated with the increased neutropenia risk in patients (compare with genotypes CC + CT)		[ 20]
Cyclophosphamide	Drug Info	Breast Neoplasm	Correlated with the increased neutropenia risk in patients (compare with genotypes CC + CT)		[ 20]
Carbamazepine	Drug Info	Epilepsy	Irrelevant to the drug resistance in patients (compare with genotype CC)		[ 18]
Oxcarbazepine	Drug Info	Epilepsy	Irrelevant to the drug resistance in patients (compare with genotype CC)		[ 18]
Genotypes CT + TT	Click to Show/Hide the Full List of Affected Drugs:            6 Drugs in Total
Tacrolimus	Drug Info	Kidney Transplantation	Correlated with the decreased drug dose in patients (compare with genotype CC); Correlated with the increased drug dose-adjusted trough concentrations in patients (compare with genotype CC)		[ 32]
Carbamazepine	Drug Info	Epilepsy	Correlated with the decreased drug metabolism in patients (compare with genotype CC)		[ 33]
Fluorouracil	Drug Info	Breast Neoplasm	Correlated with the increased nausea risk in patients (compare with genotype CC)		[ 20]
Doxorubicin	Drug Info	Breast Neoplasm	Correlated with the increased nausea risk in patients (compare with genotype CC)		[ 20]
Cyclophosphamide	Drug Info	Breast Neoplasm	Correlated with the increased nausea risk in patients (compare with genotype CC)		[ 20]
Antiepileptics	N.A.	Epilepsy	Correlated with the increased drug resistance in patients (compare with genotype CC); Irrelevant to the increased drug resistance in patients (compare with genotype CC)		[ 10], [ 15]
Genetic Polymorphism	rs717620
Site of GPD	chr10:99782821 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	C>T
Minor Allele Frequency	T=0.1350/676 (Global)
Allele C	Click to Show/Hide the Full List of Affected Drugs:            2 Drugs in Total
Methotrexate	Drug Info	Leukemia	Irrelevant to the nephrotoxicity risk in patients (compare with Allele T); Irrelevant to the prolonged high drug concentrations risk patients (compare with Allele T)		[ 34]
Antiepileptics	N.A.	Epilepsy	Irrelevant to the drug resistance in patients (compare with Allele T)		[ 12]
Allele T	Click to Show/Hide the Full List of Affected Drugs:            7 Drugs in Total
Methotrexate	Drug Info	Precursor Cell Lymphoblastic Leukemia-Lymphoma	Correlated with the decreased drug clearance in patients (compare with Allele C); Correlated with the increased drug toxicity risk in patients (compare with Allele C )		[ 35]
Mycophenolic acid	Drug Info	Kidney Transplantation	Correlated with the drug exposure in patients (compare with allele C)		[ 6]
Lopinavir	Drug Info	HIV Infection	Correlated with the increased drug toxicity risk (compare with Genotype CC)		[ 37]
Ritonavir	Drug Info	HIV Infection	Correlated with the increased drug toxicity risk (compare with Genotype CC)		[ 37]
Tenofovir	Drug Info	HIV Infection	Correlated with the increased drug toxicity risk (compare with Genotype CC); Irrelevant to the likelihood of kidney diseases in patients (compare with allele C)		[ 8], [ 37]
Atazanavir	Drug Info	HIV Infection	Correlated with the increased drug toxicity risk (compare with Genotype CC)		[ 37]
Antiepileptics	N.A.	Epilepsy	Irrelevant to the number of seizures per year in patients (compare with allele C)		[ 10]
Genotype CC	Click to Show/Hide the Full List of Affected Drugs:            5 Drugs in Total
Fluorouracil	Drug Info	Colonic Neoplasm	Correlated with the increased drug toxicity risk in patients (compare with Genotypes CT + TT)		[ 37]
Leucovorin	Drug Info	Colonic Neoplasm	Correlated with the increased drug toxicity risk in patients (compare with Genotypes CT + TT)		[ 37]
Oxaliplatin	Drug Info	Colonic Neoplasm	Correlated with the increased drug toxicity risk in patients (compare with Genotypes CT + TT)		[ 37]
Sorafenib	Drug Info	Renal Cell Carcinoma	Correlated with the increased exanthema risk in patients (compare with genotype Ct)		[ 38]
Tenofovir	Drug Info	HIV Infection	Correlated with the increased kidney tubular dysfunction risk in patients (compare with Genotypes CT + TT); Irrelevant to the increased renal proximal tubulopathy risk in patients (compare with Genotypes CT + TT)		[ 3], [ 4]
Genotype CT	Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Tamoxifen	Drug Info	Breast Neoplasm	Correlated with the increased drug response in patients (compare with genotype CC)		[ 39]
Genotype TT	Click to Show/Hide the Full List of Affected Drugs:            5 Drugs in Total
Erythromycin	Drug Info	Bacterial Infections	Correlated with the increased drug metabolism (compare with genotypes CC + CT)		[ 40]
Fluorouracil	Drug Info	Colorectal Neoplasm	Correlated with the increased severity of neurotoxicity syndromes in patients (compare with genotypes CC + CT)		[ 41]
Leucovorin	Drug Info	Colorectal Neoplasm	Correlated with the increased severity of neurotoxicity syndromes in patients (compare with genotypes CC + CT)		[ 41]
Oxaliplatin	Drug Info	Colorectal Neoplasm	Correlated with the increased severity of neurotoxicity syndromes in patients (compare with genotypes CC + CT)		[ 41]
Efavirenz	Drug Info	HIV Infection	Correlated with the increased drug concentrations in patients (compare with genotypes CC + CT)		[ 42]
Genotypes CT + TT	Click to Show/Hide the Full List of Affected Drugs:            6 Drugs in Total
Atorvastatin	Drug Info	Hypercholesterolemia	Correlated with the decreased drug response in patients (compare with genotype CC)		[ 43]
Methotrexate	Drug Info	Lymphoid	Correlated with the increased drug clearance in patients (compare with genotype CC)		[ 44]
Leucovorin	Drug Info	Leukemia	Correlated with the increased drug distribution volume in patients (compare with genotype CC)		[ 44]
Carbamazepine	Drug Info	Epilepsy	Irrelevant to the drug response in patients (compare with genotype CC)		[ 23]
Tenofovir	Drug Info	HIV Infection	Irrelevant to the glomerular disease in patients (compare with genotype CC)		[ 26]
Antiepileptics	N.A.	Epilepsy	Correlated with the increased drug resistance in patients (compare with genotype CC); Irrelevant to the increased drug resistance in patients (compare with genotype CC)		[ 10], [ 15], [ 49]
Genetic Polymorphism	rs7917432
Site of GPD	chr10:68399112 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	T>C
Minor Allele Frequency	C=0.3087/1546 (Global)
Genotype CT	Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Tenofovir	Drug Info	HIV Infection	Correlated with the decreased drug clearance in patients (compare with genotype CC)		[ 7]
Genetic Polymorphism	rs8187707
Site of GPD	chr10:99850776 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	C>T
Minor Allele Frequency	T=0.0310/155 (Global)
Allele T	Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Tenofovir	Drug Info	HIV Infection	Correlated with the decreased drug clearance in patients (compare with genotype CC)		[ 7]
Genetic Polymorphism	rs8187710
Site of GPD	chr10:99851537 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	G>A
Minor Allele Frequency	A=0.0679/340 (Global)
Allele A	Click to Show/Hide the Full List of Affected Drugs:            2 Drugs in Total
Lopinavir	Drug Info	HIV Infection	Correlated with the higher drug accumulation in patients (compare with genotype GG)		[ 46]
Doxorubicin	Drug Info	Non-Hodgkin Lymphoma	Correlated with the increased cardiotoxicity risk in patients (compare with allele G)		[ 5]
Genetic Polymorphism	rs4148386
Site of GPD	chr10:99788711 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	G>A
Minor Allele Frequency	G=0.3886/1946 (Global)
Genotypes AA + AG	Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Carbamazepine	Drug Info	Epilepsy	Correlated with the increased drug clearance in patients (compare with genotype GG)		[ 33]
References
1	Association of genetic polymorphism in ABCC2 with hepatic multidrug resistance-associated protein 2 expression and pravastatin pharmacokinetics. Pharmacogenet Genomics. 2006 Nov;16(11):801-8.
2	The relationship of polymorphisms in ABCC2 and SLCO1B3 with docetaxel pharmacokinetics and neutropenia: CALGB 60805 (Alliance). Pharmacogenet Genomics. 2013 Jan;23(1):29-33.
3	Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathy. J Infect Dis. 2006 Dec 1;194(11):1481-91.
4	Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic study. Clin Infect Dis. 2009 Jun 1;48(11):e108-16.
5	NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity. Circulation. 2005 Dec 13;112(24):3754-62.
6	Steady-state pharmacokinetics of mycophenolic acid in renal transplant patients: exploratory analysis of the effects of cyclosporine, recipients' and donors' ABCC2 gene variants, and their interactions. Eur J Clin Pharmacol. 2017 Sep;73(9):1129-1140.
7	A pharmacogenetic candidate gene study of tenofovir-associated Fanconi syndrome. Pharmacogenet Genomics. 2015 Feb;25(2):82-92.
8	A Single-Nucleotide Polymorphism in ABCC4 Is Associated with Tenofovir-Related Beta2-Microglobulinuria in Thai Patients with HIV-1 Infection. PLoS One. 2016 Jan 25;11(1):e0147724.
9	Clinical-pharmacogenetic predictive models for MTX discontinuation due to adverse events in rheumatoid arthritis. Pharmacogenomics J. 2017 Oct;17(5):412-418.
10	Lack of association between ABCC2 gene variants and treatment response in epilepsy. Pharmacogenomics. 2012 Jan;13(2):185-90.
11	Gene-wide tagging study of the association between ABCC2, ABCC5 and ABCG2 genetic polymorphisms and multidrug resistance in epilepsy. Pharmacogenomics. 2011 Mar;12(3):319-25.
12	Lack of association between polymorphism in ABCC2 gene and response to antiepileptic drug treatment in Croatian patients with epilepsy. Coll Antropol. 2013 Mar;37(1):41-5.
13	Impact of ABCC2 genotype on antiepileptic drug response in Caucasian patients with childhood epilepsy. Pharmacogenet Genomics. 2011 Oct;21(10):624-30.
14	Population pharmacogenetic pharmacokinetic modeling for flip-flop phenomenon of enteric-coated mycophenolate sodium in kidney transplant recipients. Eur J Clin Pharmacol. 2014 Oct;70(10):1211-9.
15	ABCC2 polymorphisms and haplotype are associated with drug resistance in Chinese epileptic patients. CNS Neurosci Ther. 2012 Aug;18(8):647-51.
16	Methotrexate (MTX) pathway gene polymorphisms and their effects on MTX toxicity in Caucasian and African American patients with rheumatoid arthritis. J Rheumatol. 2008 Apr;35(4):572-9.
17	Impact of Single Nucleotide Polymorphisms (SNPs) on Immunosuppressive Therapy in Lung Transplantation. Int J Mol Sci. 2015 Aug 25;16(9):20168-82.
18	Association of SCN1A, SCN2A and ABCC2 gene polymorphisms with the response to antiepileptic drugs in Chinese Han patients with epilepsy. Pharmacogenomics. 2014 Jul;15(10):1323-36.
19	Influence of single-nucleotide polymorphisms on deferasirox C trough levels and effectiveness. Pharmacogenomics J. 2015 Jun;15(3):263-71.
20	Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients. Oncotarget. 2018 Jan 10;9(10):9114-9136.
21	Population pharmacokinetics of unbound mycophenolic acid in adult allogeneic haematopoietic cell transplantation: effect of pharmacogenetic factors. Br J Clin Pharmacol. 2013 Feb;75(2):463-75.
22	Association of ATP-binding cassette, sub-family C, number 2 (ABCC2) genotype with pharmacokinetics of irinotecan in Japanese patients with metastatic colorectal cancer treated with irinotecan plus infusional 5-fluorouracil/leucovorin (FOLFIRI). Biol Pharm Bull. 2008 Nov;31(11):2137-42.
23	A comprehensive functional and clinical analysis of ABCC2 and its impact on treatment response to carbamazepine. Pharmacogenomics J. 2014 Oct;14(5):481-7.
24	A nonsynonymous variation in MRP2/ABCC2 is associated with neurological adverse drug reactions of carbamazepine in patients with epilepsy. Pharmacogenet Genomics. 2010 Apr;20(4):249-56.
25	Clinical-pharmacogenetic models for personalized cancer treatment: application to malignant mesothelioma. Sci Rep. 2017 Apr 19;7:46537.
26	Drug Transporter Genetic Variants Are Not Associated with TDF-Related Renal Dysfunction in Patients with HIV-1 Infection: A Pharmacogenetic Study. PLoS One. 2015 Nov 4;10(11):e0141931.
27	Significant effect of polymorphisms in CYP2D6 and ABCC2 on clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients. J Clin Oncol. 2010 Mar 10;28(8):1287-93.
28	Association of CYP3A4/5, ABCB1 and ABCC2 polymorphisms and clinical outcomes of Thai breast cancer patients treated with tamoxifen. Pharmgenomics Pers Med. 2013 Aug 26;6:93-8.
29	Polymorphisms in the methotrexate transport pathway: a new tool for MTX plasma level prediction in pediatric acute lymphoblastic leukemia. Pharmacogenet Genomics. 2013 Feb;23(2):53-61.
30	Attempted validation of 44 reported SNPs associated with tacrolimus troughs in a cohort of kidney allograft recipients. Pharmacogenomics. 2018 Feb;19(3):175-184.
31	Integrated pharmacogenetic prediction of irinotecan pharmacokinetics and toxicity in patients with advanced non-small cell lung cancer. Lung Cancer. 2009 Jan;63(1):115-20.
32	Influence of ABCC2, CYP2C8, and CYP2J2 Polymorphisms on Tacrolimus and Mycophenolate Sodium-Based Treatment in Brazilian Kidney Transplant Recipients. Pharmacotherapy. 2017 May;37(5):535-545.
33	Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy. Pharmacogenomics. 2013 Jan;14(1):35-45.
34	Influence of pre-hydration and pharmacogenetics on plasma methotrexate concentration and renal dysfunction following high-dose methotrexate therapy. Int J Hematol. 2013 Dec;98(6):702-7.
35	Association of ABCC2 -24C>T polymorphism with high-dose methotrexate plasma concentrations and toxicities in childhood acute lymphoblastic leukemia. PLoS One. 2014 Jan 3;9(1):e82681.
36	Polymorphisms associated with renal adverse effects of antiretroviral therapy in a Southern Brazilian HIV cohort. Pharmacogenet Genomics. 2015 Nov;25(11):541-7.
37	Pharmacogenetic analysis of adjuvant FOLFOX for Korean patients with colon cancer. Cancer Chemother Pharmacol. 2013 Apr;71(4):843-51.
38	Risk factors for sorafenib-induced high-grade skin rash in Japanese patients with advanced renal cell carcinoma. Anticancer Drugs. 2013 Mar;24(3):310-4.
39	ABCB1 and ABCC2 and the risk of distant metastasis in Thai breast cancer patients treated with tamoxifen. Onco Targets Ther. 2016 Apr 12;9:2121-9.
40	Effect of ABCC2 (MRP2) transport function on erythromycin metabolism. Clin Pharmacol Ther. 2011 May;89(5):693-701.
41	A prospective validation pharmacogenomic study in the adjuvant setting of colorectal cancer patients treated with the 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX4) regimen. Pharmacogenomics J. 2013 Oct;13(5):403-9.
42	Efavirenz pharmacogenetics in a cohort of Italian patients. Int J Antimicrob Agents. 2016 Feb;47(2):117-23.
43	Gender-Specific Association Between ABCC2 -24C>T SNP and Reduction in Triglycerides in Chilean Patients Treated With Atorvastatin. Basic Clin Pharmacol Toxicol. 2018 May;122(5):517-522.
44	Impact of ABCC2 polymorphisms on high-dose methotrexate pharmacokinetics in patients with lymphoid malignancy. Pharmacogenomics J. 2013 Dec;13(6):507-13.
45	The ABCC2 c.-24C>T polymorphism increases the risk of resistance to antiepileptic drugs: A meta-analysis. J Clin Neurosci. 2017 Mar;37:6-14.
46	Association between ABCC2 polymorphism and lopinavir accumulation in peripheral blood mononuclear cells of HIV-infected patients. Pharmacogenomics. 2009 Oct;10(10):1589-97.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.